enprofylline has been researched along with Endotoxemia in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nadai, M | 1 |
| Hasegawa, T | 1 |
| Wang, L | 1 |
| Haghgoo, S | 1 |
| Okasaka, T | 1 |
| Nabeshima, T | 1 |
| Kato, N | 1 |
1 other study available for enprofylline and Endotoxemia
| Article | Year |
|---|---|
Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Endotoxemia; Kidney; Kinetics; Klebsiella pneumoni | 1996 |